Press Releases OmniAb, Inc.

Equities

OABI

US68218J1034

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-21 EDT			5-day change	1st Jan Change
3.99 ^USD	-1.72%		-5.45%	-35.33%

05-29	Omniab Insider Bought Shares Worth $1,059,840, According to a Recent SEC Filing	MT
05-09	Earnings Flash (OABI) OMNIAB Reports Q1 Revenue $3.8M, vs. Street Est of $5.9M	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OmniAb : Submission of Matters to a Vote of Security Holders Form 8 K	06-21	PU
OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology	06-03	BU
OmniAb to Participate in the Jefferies Global Healthcare Conference	05-20	BU
OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit	05-15	BU
OmniAb : May 2024 Corporate Overview	05-09	PU
OmniAb Reports First Quarter 2024 Financial Results and Business Highlights	05-09	BU
OmniAb to Participate in Five Investor Conferences in May	05-01	BU
OmniAb to Report First Quarter 2024 Financial Results on May 9	04-22	BU
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate Biotherapeutics	04-16	AQ
OmniAb : March 2024 Corporate Overview	03-26	PU
OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights	03-20	BU
OmniAb to Report Fourth Quarter 2023 Financial Results on March 20	02-26	BU
OmniAb to Participate in Two Investor Conferences in March	02-20	BU
OmniAb Presents New Scientific Data on its OmnidAb Platform at the 2023 Antibody Engineering and Therapeutics Conference	12-15	AQ
OmniAb Presents New Scientific Data on its OmnidAb™ Platform at the 2023 Antibody Engineering & Therapeutics Conference	12-14	BU
OmniAb Highlights OmnidAb™ Launch and its Expanding Drug Discovery Platform at Today’s Research & Technology Virtual Event	11-09	BU
OmniAb Reports Third Quarter 2023 Financial Results and Business Highlights	11-09	BU
OmniAb to Participate in Two Investor Conferences in November	11-02	BU
OmniAb Appoints Steve Love to its Board of Directors	11-01	BU
OmniAb Announces Agenda for its Research & Technology Virtual Event	23-10-31	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases OmniAb, Inc.

Equities

OABI

US68218J1034

Press Releases

Filters